Frontlight ResearchEarly access
Glioblastoma trials in United States
199 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Early phase 1Taking peoplePilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
- Where
- Nashville
- Age
- 18 years and over
- People
- 30
- Run by
- Eben Rosenthal
See details and how to joinNCT07493447 - Phase 2Not yet taking people in United StatesThe GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma
- Where
- Baltimore
- Age
- 18 years to 70 years
- People
- 40 worldwide
- Run by
- T-MAXIMUM Pharmaceutical Inc
See details and how to joinNCT07386002 - Phase 2Taking peoplePre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.
- Where
- Camden
- Age
- 18 years to 80 years
- People
- 70
- Run by
- Cooper Norcross Health
See details and how to joinNCT07439172 - Phase 1Taking peopleTMZ + RT + 5-ALA + LIDU SDT System for Newly Diagnosed Butterfly Glioma
- Where
- Buffalo
- Age
- 18 years to 80 years
- People
- 30
- Run by
- Alpheus Medical, Inc.
See details and how to joinNCT07862647 - Phase 1/2Taking peopleBiologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 50
- Run by
- Jonsson Comprehensive Cancer Center
See details and how to joinNCT06059690 - Phase 1/2Taking peopleRadiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- Where
- Gilbert, Seattle, Tucson
- Age
- 18 years to 99 years
- People
- 30
- Run by
- University of Arizona
See details and how to joinNCT06814496 - Phase 2Not yet taking people in United StatesEfficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade Glioma
- Where
- Birmingham
- Age
- 12 years to 89 years
- People
- 55
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT07521657 - Phase 1/2Not yet taking people in United StatesMetronomic Temozolomide With Dexbrompheniramine for Recurrent High-Grade Glioma/Glioblastoma
- Where
- Omaha
- Age
- 19 years and over
- People
- 41
- Run by
- University of Nebraska
See details and how to joinNCT07859059 - Phase 2Taking peopleRuxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
- Where
- Miami, New York
- Age
- 18 years and over
- People
- 190
- Run by
- Baptist Health South Florida
See details and how to joinNCT06991101 - Phase 1Taking peopleGPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
- Where
- Houston
- Age
- 21 years to 70 years
- People
- 27
- Run by
- Baylor College of Medicine
See details and how to joinNCT06815432 - Phase 2Taking peopleThe Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 27
- Run by
- Mayo Clinic
See details and how to joinNCT07285044 - Phase 1Taking peopleLaser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
- Where
- Sacramento
- Age
- 18 years and over
- People
- 25
- Run by
- University of California, Davis
See details and how to joinNCT07145112 - Phase 1Taking peopleMSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
- Where
- Houston
- Age
- 18 years and over
- People
- 36
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03896568 - Phase 1/2Taking peopleA Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Where
- Atlanta, Aurora, Boston, Charlotte, Cleveland, Dallas, Hershey, Houston, Los Angeles, Memphis, New Brunswick, New York, Orlando, Philadelphia, Richmond, Scarborough, St Louis
- Age
- Up to 25 years
- People
- 75 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00 - Phase 1Not yet taking people in United StatesA Phase I First-in-human Trial of Bvax (B-cell Vaccination) in Addition to Standard of Care Chemoradiotherapy for Newly Diagnosed Glioblastoma
- Where
- Chicago
- Age
- 18 years and over
- People
- 25
- Run by
- Catalina Lee Chang
See details and how to joinNCT07422896 - Phase 1/2Taking peopleSafety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Where
- Beverly Hills, Boston, Boynton Beach, Dallas, Glendale, Los Angeles, Nashville, Tacoma
- Age
- 18 years and over
- People
- 134
- Run by
- Neonc Technologies, Inc.
See details and how to joinNCT06047379 - Phase 2Taking peopleOPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
- Where
- Gainesville
- Age
- 18 years to 90 years
- People
- 20
- Run by
- University of Florida
See details and how to joinNCT06558214 - Early phase 1Not yet taking people in United StatesOral Gallium Maltolate for Recurrent Glioblastoma
- Where
- Milwaukee
- Age
- 18 years and over
- People
- 8
- Run by
- Medical College of Wisconsin
See details and how to joinNCT07515924 - Phase 2Not yet taking people in United StatesPhase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Treated With Cesium-131 GammaTile®
- Where
- Orange
- Age
- 18 years and over
- People
- 20
- Run by
- University of California, Irvine
See details and how to joinNCT07821112 - Phase 1/2Taking peopleTrial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 10
- Run by
- Chirag G. Patil
See details and how to joinNCT04977375 - Phase 2Taking peopleVISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma
- Where
- Fairfax
- Age
- 18 years to 98 years
- People
- 52
- Run by
- Inova Health Care Services
See details and how to joinNCT07831369 - No phaseTaking peopleREMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma
- Where
- Minneapolis
- Age
- 18 years and over
- People
- 4
- Run by
- University of Minnesota
See details and how to joinNCT07831772 - Phase 2Taking peopleFeasibility of FMISO in Brain Tumors
- Where
- Portland
- Age
- 18 years and over
- People
- 77
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT03649880 - Phase 1Taking peopleERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
- Where
- Los Angeles, New York
- Age
- 18 years and over
- People
- 50
- Run by
- Jonsson Comprehensive Cancer Center
See details and how to joinNCT07089641 - Phase 2Taking peopleTrial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
- Where
- Durham, Houston, New York
- Age
- 18 years and over
- People
- 92 worldwide
- Run by
- Duke University
See details and how to joinNCT06816927